Effect of antipsychotic drugs on the gene expression of NMDA receptor subunits in rats

Neurochemical Research

Volumn 22, Issue 3, 1997, Pages 249-252

  Toyoda, Hirotaka ^a   Takahata, Ryuichi ^a   Inayama, Yasuhiro ^a   Sakai, Jun ^a   Matsumura, Hitoshi ^b   Yoneda, Hiroshi ^a   Asaba, Hiroyuki ^a   Sakai, Toshiaki ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b OSAKA BIOSCIENCE INSTITUTE   (Japan)

Author keywords

Gene expression; haloperidol; NMDA receptor; rat whole brain; sulpiride

Indexed keywords

HALOPERIDOL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROLEPTIC AGENT; RECEPTOR SUBUNIT; SULPIRIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION REGULATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MESSENGER RNA SYNTHESIS; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; SCHIZOPHRENIA;

ANIMALS; ANTIPSYCHOTIC AGENTS; BRAIN; GENE EXPRESSION REGULATION; HALOPERIDOL; MALE; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; SULPIRIDE;

ANIMALIA;

EID: 0031048179     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022426402611     Document Type: Article

References (28)

1. Moriyoshi, K., Masu, M., Ishii, T., Shigemoto, R., Mizuno, N., and Nakanishi, S. 1991. Molecular cloning and characterization of the rat NMDA receptors. Nature 354:31-37.
2. Meguro, H., Mori, H., Araki, K., Kushiya, E., Kutsuwada, T., Yamazaki, M., Kumanishi, T., Arakawa, M., Sakimura, K., and Mishina, M. 1992. Functional characterization of a heteromeric NMDA receptor channel expressed from cloned cDNAs. Nature 357:70-74.
3. Yamazaki, M., Mori, H., Araki, K., Mori, K. J., and Mishina, M. 1992. Cloning, expression and modulation of a mouse NMDA receptor subunit. FEBS Lett. 300:39-45.
4. Kutsuwada, T., Kashiwabuchi, N., Mori, H., Sakimura, K., Kushiya, E., Araki, K., Meguro, H., Masaki, H., Kumanishi, T., Arakawa, M., and Mishina, M. 1992. Molecular diversity of the NMDA receptor channel. Nature 358:36-41.
5. Monyer, H., Sprengel, R., Schoepfer, R., Herb, A., Higuchi, M., Lomeli, H., Burnashev, N., Sakmann, B., and Seeburg, P. H. 1992. Heteromeric NMDA receptors: Molecular and functional distinction of subtypes. Science 256:1217-1221.
6. Ikeda, K., Nagasawa, M., Mori, H., Araki, K., Sakimura, K., Watanabe, M., Inoue, Y., and Mishina, M. 1992. Cloning and expression of the ε 4 subunit of the NMDA receptor channel. FEBS Lett. 313:34-38.
7. Ishii, T., Moriyoshi, K., Sugihara, H., Sakurada, K., Kadotani, H., Yokoi, M., Akazawa, C., Shigemoto, R., Mizuno, N., Masu, M., and Nakanishi, S. 1993. Molecular characterization of the family of N-methyl-D-asparatate receptor subunits. J. Biol. Chem. 268: 2836-2843.
8. Javitt, D. C. 1987. Negative schizophrenic symptomatology and the PCP (phencyclidine) model of schizophrenia. Hillside J. Clin. Psychiatry 9:12-35.
9. Javitt, D. C., and Zukin, S. R. 1991. Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiat. 148:1301-1308.
10. Johnson, K. M., Snell, L. D., Sacaan, A. I., and Jones, S. M. 1989. Pharmacological regulation of the phencyclidine- binding site associated with the N-methyl-D-asparatate receptor operated ion channel. Drug Dev. Res. 17:281-297.
11. Carlsson, M., and Carlsson, A. 1990. Interactions between glutamatergic and monoaminergic systems within the basal ganglia - implications for schizophrenia and Parkinson's disease. Trends Neurosci. 13(7):272-277.
12. Toru, M., Watanabe, S., Shibuya, H., Nishikawa, T., Noda, K., Mitsushio, H., Ichikawa, H., Kurumaji, A., Takashima, M., Mataga, N., and Ogawa, A. 1988. Neurotransmitters, receptors and neuropeptides in post mortem brains of chronic schizophrenic patients. Acta Psychiatr. Scand. 78:121-137.
13. Deakin, J. F. W., Slatter, P., Simpson, M. D. C., Gilchrist, A. C., Skan, W. J., Royston, M. C., Reynolds, G. P., and Cross, A. J. 1989. Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia. J. Neurochem. 52:1781-1786.
14. Harrison, P. J., McLaughlin, D., and Kerwin, R. W. 1991. Decreased hippocampal expression of a glutamate receptor gene in schizophrenia. Lancet 337:450-452.
15. Kim, J. S., Kornhuber, H. H., Schmid-Burgk, W., and Holzmüler, B. 1980. Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia. Neurosci. Lett. 20: 379-382.
16. Deutsch, S. I., Mastropaolo, J., Schwartz, B. L., Rose, R. N., and Morihisa, J. M. 1989. A glutamatergic hypothesis of schizophrenia. Rationale for pharmacotherapy with glycine. Clin. Neuropharmacol. 12:1-13.
17. Kornhuber, J., and Kornhuber, M. E. 1986. Presynaptic dopamine modulation of cortical input to the striatum. Life Sci. 39:669-674.
18. Giorgueff, M. F., Kemel, M. L., and Glowinski, J. 1977. Presynaptic effect of L-glutamic acid on the release of dopamine in rat striatal slices. Neurosci. Lett. 6:73-77.
19. Leviel, V., Gobert, A., and Guibert, B. 1990. The glutamate-mediated release of dopamine in the rat striatum: further characterization of the dual excitatory-inhibitory function. Neuroscience 39: 305-312.
20. Krebs, M. F., Desce, J. M., Kernel, M. L., Gauchy, C., Godeheu, G., Cheramy, A., and Glowinski, J. 1991. Glutamatergic control of dopamine release in the rat striatum: evidence for presynaptic N-methyl-D-asparatate receptors on dopaminergic terminals. J. Neurochem. 56:81-85.
21. Micheletti, G., Lannes, B., Warter, J. M., and Zwiller, J. 1993. Evidence for NMDA/D2 receptor-receptor interactions in the rat striatum. Pages 128-132, in Narabayashi, H., Nagatsu, T., Yanagisawa, N., and Mizuno, Y. (eds.), Advances in Neurology, Raven Press, New York.
22. Johnstone, E. C., Crow, T. J., Frith, C. D., Carney, M. W. P., and Prince, J. S. 1978. Mechanism of the antipsychotic effect in the treatment of acute schizophrenia. Lancet 22:848-851.
23. Freed, W. J. 1988. The therapeutic latency of neuroleptic drugs and nonspecific postjunctional supersensitivity. Schizophrenia Bull. 14(2):269-277.
24. Chomczynski, P., and Sacchi, N. 1977. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extractions. Anal. Biochem. 162:156.
25. Ponte, P., Ng, S.-Y., Engel, J., Gunning, P., and Kedes, L. 1984. Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA. Nucleic Acids Res. 12:1687-1691.
26. Eastwood, S. L., Story, P., Burnet, P. W. J., Heath, P., and Harrison, P. J. 1994. Differential changes in glutamate receptor subunit messenger RNAs in rat brain after haloperidol treatment. J. Psychopharmacol. 8(4): 196-203.
27. Oretti, R. G., Spurlock, G., Buckland, P. R., and McGuffin, P. 1994. Lack of effect of antipsychotic and antidepressant drugs on glutamate receptor mRNA levels in rat brains. Neurosci. Lett. 177: 39-43.
28. Fitzgerald, L. W., Deutch, A. Y., Gasic, G., and Heinemann, S. F. 1995. Glutamate receptor subunit expression by antipsychotic drugs. J. Neurosci. 15(3):2453-2461.